Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patients

Diabetes, Obesity and Metabolism

Volumn 16, Issue 2, 2014, Pages 137-146

  Mader, J K ^a   Neubauer, K M ^a   Schaupp, L ^a   Augustin, T ^b   Beck, P ^b   Spat, S ^b   Holl B ^a   Treiber, G M ^a   Fruhwald, F M ^a   Pieber, T R ^a,b   Plank, J ^a,c  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b JOANNEUM RESEARCH   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Glycaemic control; Insulin analogues; Insulin therapy; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LONG ACTING INSULIN;

AGED; ALGORITHM; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTOCOL COMPLIANCE; WORKFLOW; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATIENT PARTICIPATION; PHYSIOLOGIC MONITORING; REPRODUCIBILITY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BODY MASS INDEX; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INPATIENTS; INSULIN, LONG-ACTING; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PATIENT PARTICIPATION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WORKFLOW;

EID: 84892479062     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12186     Document Type: Article

References (36)

1. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008; 31: 596-615.
2. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002; 87: 978-982.
3. Clement S, Braithwaite SS, Magee MF et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27: 553-591.
4. Pomposelli JJ, Baxter JK, Babineau TJ et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J Parenter Enteral Nutr 1998; 22: 77-81.
5. National Health Service GB. National Diabetes Inpatient Audit 2011. London: NHS Diabetes, 2011. Available from URL: https://catalogue.ic.nhs.uk/publications/clinical/diabetes/nati-diab-inp-audi-11/nati-diab-inp-audi-11-nat-rep.pdf. Accessed 11 February 2013.
6. Murad MH, Coburn JA, Coto-Yglesias F et al. Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. J Clin Endocrinol Metab 2012; 97: 49-58.
7. Umpierrez GE, Hellman R, Korytkowski MT et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 16-38.
8. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2012; 36: S11-66.
9. Umpierrez GE, Smiley D, Zisman A et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 2007; 30: 2181-2186.
10. Umpierrez GE, Smiley D, Jacobs S et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 2011; 34: 256-261.
11. Umpierrez GE, Hor T, Smiley D et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab 2009; 94: 564-569.
12. Neubauer KM, Schaupp L, Plank J etal. Failure to control hyperglycemia in noncritically ill diabetes patients despite standard glycemic management in a hospital setting. J Diabetes Sci Technol 2013; 7: 402-409.
13. R Development Research Group. R: A Language and Environment for Statistical Computing [Internet]. Vienna: R Foundation for Statistical Computing, 2008. Available from URL: http://www.r-project.org. Accessed 11 February 2013.
14. Hamann A, Matthaei S, Rosak C, Silvestre L. A randomized clinical trial comparing administration of insulin glargine in patients with type 1 diabetes - for the HOE901/4007 study group. Diabetes Care 2003; 26: 1738-1744.
15. Zijlstra E, Heise T, Nosek L, Heinemann L, Heckermann S. Continuous glucose monitoring: quality of hypoglycaemia detection. Diabetes Obes Metab 2013; 15: 130-135.
16. Klonoff DC, Buckingham B, Christiansen JS et al. Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96: 2968-2979.
17. Mathieu C, Robbrecht S. Reaching glycaemic targets while minimizing hypoglycaemia in insulin-treated type 2 diabetes patients. Diabetes Obes Metab 2008; 10: S14-23.
18. Farrokhi F, Klindukhova O, Chandra P et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. J Diabetes Sci Technol 2012; 6: 1022-1029.
19. Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med 2011; 124: 1028-1035.
20. Rubin DJ, Rybin D, Doros G, McDonnell ME. Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes. Diabetes Care 2011; 34: 1723-1728.
21. Baldwin D, Zander J, Munoz C et al. A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency. Diabetes Care 2012; 35: 1970-1974.
22. Hirose M, Yamanaka H, Ishikawa E, Sai A, Kawamura T. Easy and flexible carbohydrate counting sliding scale reduces blood glucose of hospitalized diabetic patient in safety. Diabetes Res Clin Pract 2011; 93: 404-409.
23. Davidson PC, Hebblewhite HR, Steed RD, Bode BW. Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract 2008; 14: 1095-1101.
24. Bergenstal RM, Johnson M, Powers MA et al. Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care 2008; 31: 1305-1310.
25. Umpierrez GE, Gianchandani R, Smiley D et al. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study. Diabetes Care 2013; 36: 3430-3435.
26. Ammenwerth E, Schnell-Inderst P, Machan C, Siebert U. The effect of electronic prescribing on medication errors and adverse drug events: a systematic review. J Am Med Inform Assoc 2008; 15: 585-600.
27. Rothschild J. Computerized physician order entry in the critical care and general inpatient setting: a narrative review. J Crit Care 2004; 19: 271-278.
28. Eslami S, De Keizer NF, Abu-Hanna A. The impact of computerized physician medication order entry in hospitalized patients--a systematic review. Int J Med Inform 2008; 77: 365-376.
29. Chaudhry B, Wang J, Wu S et al. Systematic review: impact of health information technology on quality, efficiency, and costs of medical care. Ann Intern Med 2006; 144: 742-752.
30. Garg AX, Adhikari NK, McDonald H et al. Effects of computerized clinical decision support systems on practitioner performance. JAMA 2005; 293: 1223-1238.
31. Draznin B, Gilden J, Golden SH, Inzucchi SE. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013; 36: 1807-1814.
32. Nirantharakumar K, Chen YF, Marshall T, Webber J, Coleman JJ. Clinical decision support systems in the care of inpatients with diabetes in non-critical care setting: systematic review. Diabet Med 2012; 29: 698-708.
33. Wexler DJ, Shrader P, Burns SM, Cagliero E. Effectiveness of a computerized insulin order template in general medical inpatients with type 2 diabetes: a cluster randomized trial. Diabetes Care 2010; 33: 2181-2183.
34. Schnipper JL, Liang CL, Ndumele CD, Pendergrass ML. Effects of a computerized order set on the inpatient management of hyperglycemia: a cluster-randomized trial. Endocr Pract 2010; 16: 209-218.
35. Moxey A, Robertson J, Newby D, Hains I, Williamson M, Pearson SA. Computerized clinical decision support for prescribing: provision does not guarantee uptake. J Am Med Inform Assoc 2010; 17: 25-33.
36. Phansalkar S, Edworthy J, Hellier E et al. A review of human factors principles for the design and implementation of medication safety alerts in clinical information systems. J Am Med Inform Assoc 2010; 17: 493-501.